Changes in Metastatic Castration Sensitive Prostate Cancer
Journal Title: The Bulletin of Urooncology - Year 2021, Vol 20, Issue 1
Abstract
Prostate cancer is the second most common cancer in men worldwide, with approximately 1,276,106 new patients and 358,989 new deaths. Metastatic castrationsensitive prostate cancer may be de novo metastatic, but also it may be in the localized disease stage at the time of diagnosis, and may present as biochemical relapse and later metastatic disease over time. Purposes of metastatic castration-sensitive prostate cancer treatment are prolonging survival, improving quality of life and reducing complications. In this review, it is aimed to evaluate the current developments in metastatic castration-sensitive prostate cancer treatment.
Authors and Affiliations
Mustafa Gürbüz, Yüksel Ürün
Keywords
Related Articles
- EP ID EP693527
- DOI 10.4274/uob.galenos.2019.1407
- Views 92
- Downloads 0
Evaluation of the Risk of Falls in the Patients Hospitalized in A Urology Inpatient Clinic
Objective: Falls are a significant cause of morbidity and mortality, particularly in hospitalized patients. In this study, we aimed to evaluate the risk of falls in the patients hospitalized in a urology clinic. Materia...
Evaluation of General Features of Patients with Testicular Cancer
Objective: Testicular cancers (Tca) are most common in men aged 20-34. Despite the increase in its incidence, the mortality rate from Tca decreases. In our study, it was aimed to evaluate the general characteristics, the...
The Key Steps in Robotic Radical Prostatectomy
No summary
Nuclear Medicine Applications in Diagnosis of Urological Tumors
Except for prostate carcinoma, there is limited data in the literature on the role of nuclear imaging methods in the management of urological cancers. 18F-fluorodeoxyglucose positron emission tomography/computed tomograp...
The Factors Affecting Recurrence and Prognosis in Patients with Low-grade Stage Ta Bladder Cancer
Objective: This study aims to review the parameters affecting tumour recurrence, tumour progression and cancer survival of patients with low-grade non-muscle invasive bladder cancer. Materials and Methods: We retrospect...